Want to see IN:SUVEN full AI Analyst Report?
Suven Life Sciences Limited (SUVEN) Ratios
Suven Life Sciences Limited Ratios
IN:SUVEN's free cash flow for Q4 2026 was $0.00. For the 2026 fiscal year, IN:SUVEN's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 17.69 | 3.21 | 18.99 | 22.61 | 8.01 |
| Quick Ratio | 17.69 | 3.20 | 18.94 | 22.60 | 8.01 |
| Cash Ratio | 10.92 | 1.61 | 1.10 | 3.33 | 0.63 |
| Solvency Ratio | -8.25 | -6.15 | -6.63 | -8.22 | -9.89 |
| Operating Cash Flow Ratio | -9.63 | -6.32 | -8.54 | -9.27 | -15.34 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -162.70 | 171913.67 | -263.34 |
| Net Current Asset Value | $ 5.14B | $ 502.76M | $ 2.42B | $ 2.38B | $ 547.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.03 |
| Debt-to-Equity Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.03 |
| Debt-to-Capital Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.06 | 1.23 | 1.06 | 1.04 | 1.12 |
| Debt Service Coverage Ratio | -1714.66 | -3323.53 | -97.48 | -291.75 | -102.86 |
| Interest Coverage Ratio | -1838.51 | -3682.30 | -410.66 | -320.34 | -188.92 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Interest Debt Per Share | 0.74 | 0.00 | 0.05 | 0.13 | 0.25 |
| Net Debt to EBITDA | 1.19 | 0.24 | 0.14 | 0.32 | 0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | -589.32% | -415.18% | 92.95% | 95.82% | -115.93% |
| EBIT Margin | -3881.91% | -2414.41% | -905.85% | -870.48% | -1024.35% |
| EBITDA Margin | -3803.01% | -2326.94% | -849.05% | -822.15% | -987.26% |
| Operating Profit Margin | -4077.70% | -2578.13% | -1048.35% | -974.32% | -1065.63% |
| Pretax Profit Margin | -3884.13% | -2415.11% | -907.21% | -873.52% | -1029.99% |
| Net Profit Margin | -3884.13% | -2415.11% | -898.63% | -873.52% | -1029.99% |
| Continuous Operations Profit Margin | -3884.13% | -2415.11% | -898.63% | -873.52% | -1029.99% |
| Net Income Per EBT | 100.00% | 100.00% | 99.06% | 100.00% | 100.00% |
| EBT Per EBIT | 95.25% | 93.68% | 86.54% | 89.65% | 96.66% |
| Return on Assets (ROA) | -44.27% | -118.91% | -36.88% | -30.41% | -112.92% |
| Return on Equity (ROE) | -46.73% | -146.15% | -38.91% | -31.51% | -126.89% |
| Return on Capital Employed (ROCE) | -48.90% | -153.63% | -45.17% | -34.92% | -126.57% |
| Return on Invested Capital (ROIC) | -47.56% | -153.63% | -44.51% | -34.82% | -124.53% |
| Return on Tangible Assets | -44.28% | -119.07% | -36.91% | -30.43% | -113.16% |
| Earnings Yield | -9.21% | -6.03% | -4.59% | -15.46% | -9.05% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.72 | 4.71 | 3.35 | 1.00 | 5.79 |
| Payables Turnover | 10.19 | 6.56 | 0.40 | 0.34 | 12.87 |
| Inventory Turnover | 480.81 | 144.38 | 1.16 | 71.59 | 775.00 |
| Fixed Asset Turnover | 0.09 | 0.11 | 0.42 | 0.37 | 0.29 |
| Asset Turnover | 0.01 | 0.05 | 0.04 | 0.03 | 0.11 |
| Working Capital Turnover Ratio | 0.03 | 0.05 | 0.05 | 0.09 | 0.16 |
| Cash Conversion Cycle | 42.32 | 24.35 | -493.08 | -703.04 | 35.17 |
| Days of Sales Outstanding | 77.38 | 77.46 | 108.87 | 366.21 | 63.05 |
| Days of Inventory Outstanding | 0.76 | 2.53 | 313.69 | 5.10 | 0.47 |
| Days of Payables Outstanding | 35.82 | 55.64 | 915.64 | 1074.35 | 28.35 |
| Operating Cycle | 78.14 | 79.99 | 422.56 | 371.31 | 63.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -13.06 | -6.79 | -5.30 | -6.54 | -8.08 |
| Free Cash Flow Per Share | -13.28 | -8.50 | -5.30 | -6.72 | -9.34 |
| Dividend Paid and CapEx Coverage Ratio | -58.53 | -3.98 | -1.00 | -35.63 | -6.45 |
| Capital Expenditure Coverage Ratio | -58.53 | -3.98 | -1.00 | -35.63 | -6.45 |
| Operating Cash Flow Coverage Ratio | -17.82 | 0.00 | -162.70 | -64.26 | -39.75 |
| Operating Cash Flow to Sales Ratio | -41.82 | -22.31 | -9.88 | -7.62 | -10.77 |
| Free Cash Flow Yield | -10.09% | -6.96% | -5.04% | -13.86% | -10.93% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.86 | -16.58 | -21.78 | -6.47 | -11.05 |
| Price-to-Sales (P/S) Ratio | 421.72 | 400.69 | 195.76 | 56.52 | 113.78 |
| Price-to-Book (P/B) Ratio | 5.07 | 24.25 | 8.48 | 2.04 | 14.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.91 | -14.36 | -19.82 | -7.22 | -9.15 |
| Price-to-Operating Cash Flow Ratio | -10.08 | -17.96 | -19.82 | -7.42 | -10.57 |
| Price-to-Earnings Growth (PEG) Ratio | -0.17 | -0.31 | 0.61 | 2.17 | -0.16 |
| Enterprise Value Multiple | -9.90 | -16.98 | -22.91 | -6.56 | -11.51 |
| Enterprise Value | 26.80B | 26.29B | 22.75B | 7.30B | 13.46B |
| EV to EBITDA | -9.90 | -16.98 | -22.91 | -6.56 | -11.51 |
| EV to Sales | 376.63 | 395.02 | 194.54 | 53.90 | 113.61 |
| EV to Free Cash Flow | -8.85 | -14.15 | -19.70 | -6.88 | -9.13 |
| EV to Operating Cash Flow | -9.01 | -17.71 | -19.70 | -7.08 | -10.55 |
| Tangible Book Value Per Share | 25.95 | 5.02 | 12.38 | 23.78 | 6.08 |
| Shareholders’ Equity Per Share | 25.96 | 5.03 | 12.39 | 23.79 | 6.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.01 | -0.07 | -0.01 |
| Revenue Per Share | 0.31 | 0.30 | 0.54 | 0.86 | 0.75 |
| Net Income Per Share | -12.13 | -7.36 | -4.82 | -7.50 | -7.73 |
| Tax Burden | 1.00 | 1.00 | 0.99 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.01 |
| Research & Development to Revenue | 34.88 | 21.63 | 9.79 | 8.52 | 8.98 |
| SG&A to Revenue | 0.00 | 0.40 | 0.23 | 0.19 | 0.21 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.08 | 0.92 | 1.10 | 0.87 | 1.05 |
Currency in INR